To answer ZaraB_AL's question specifically:
From a clinical standpoint, Novo Nordisk CagriSema Phase 3 is an area where we have good evidence.
The short answer: baseline labs + quarterly monitoring is the standard of care.
The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.
BiostatsBrad said:5%, triglycerides 213 → 113 mg/dL, hsCRP 8
This is exactly right. BiostatsBrad articulated what I have been trying to explain to my doctor for months. The Novo Nordisk CagriSema aspect is the most important factor.
OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on Novo Nordisk CagriSema.
To answer mike_mod: I started tracking everything in a spreadsheet from day 1.
Quick update: I will post a proper update thread soon. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesZaraB_AL said:Top-tier content
This is exactly right. ZaraB_AL articulated what I have been trying to explain to my friends for months. The Novo Nordisk CagriSema aspect is what made the difference for me.